Journey Medical (DERM) Competitors $6.99 -0.36 (-4.90%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$7.00 +0.01 (+0.21%) As of 08/1/2025 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DERM vs. FBIO, PHAR, TLRY, DNTH, MRVI, MGTX, PHAT, AUTL, XNCR, and VALNShould you be buying Journey Medical stock or one of its competitors? The main competitors of Journey Medical include Fortress Biotech (FBIO), Pharming Group (PHAR), Tilray Brands (TLRY), Dianthus Therapeutics (DNTH), Maravai LifeSciences (MRVI), MeiraGTx (MGTX), Phathom Pharmaceuticals (PHAT), Autolus Therapeutics (AUTL), Xencor (XNCR), and Valneva (VALN). These companies are all part of the "medical" sector. Journey Medical vs. Its Competitors Fortress Biotech Pharming Group Tilray Brands Dianthus Therapeutics Maravai LifeSciences MeiraGTx Phathom Pharmaceuticals Autolus Therapeutics Xencor Valneva Fortress Biotech (NASDAQ:FBIO) and Journey Medical (NASDAQ:DERM) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership and valuation. Does the media prefer FBIO or DERM? In the previous week, Journey Medical had 4 more articles in the media than Fortress Biotech. MarketBeat recorded 5 mentions for Journey Medical and 1 mentions for Fortress Biotech. Journey Medical's average media sentiment score of 0.87 beat Fortress Biotech's score of 0.75 indicating that Journey Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fortress Biotech 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Journey Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, FBIO or DERM? Journey Medical has lower revenue, but higher earnings than Fortress Biotech. Journey Medical is trading at a lower price-to-earnings ratio than Fortress Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFortress Biotech$57.67M0.93-$46M-$2.23-0.81Journey Medical$56.13M2.90-$14.67M-$0.39-17.92 Do institutionals and insiders hold more shares of FBIO or DERM? 96.5% of Fortress Biotech shares are held by institutional investors. Comparatively, 7.3% of Journey Medical shares are held by institutional investors. 27.9% of Fortress Biotech shares are held by company insiders. Comparatively, 15.0% of Journey Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more volatility and risk, FBIO or DERM? Fortress Biotech has a beta of 1.76, suggesting that its stock price is 76% more volatile than the S&P 500. Comparatively, Journey Medical has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500. Do analysts recommend FBIO or DERM? Fortress Biotech currently has a consensus target price of $21.00, suggesting a potential upside of 1,060.22%. Journey Medical has a consensus target price of $9.50, suggesting a potential upside of 35.91%. Given Fortress Biotech's higher possible upside, analysts plainly believe Fortress Biotech is more favorable than Journey Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fortress Biotech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Journey Medical 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is FBIO or DERM more profitable? Journey Medical has a net margin of -14.76% compared to Fortress Biotech's net margin of -71.24%. Journey Medical's return on equity of -52.03% beat Fortress Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Fortress Biotech-71.24% -4,712.53% -27.67% Journey Medical -14.76%-52.03%-11.28% SummaryJourney Medical beats Fortress Biotech on 9 of the 15 factors compared between the two stocks. Get Journey Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DERM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DERM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DERM vs. The Competition Export to ExcelMetricJourney MedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$171.22M$2.49B$5.48B$9.53BDividend YieldN/A1.81%4.73%4.09%P/E Ratio-17.928.9728.8623.83Price / Sales2.90433.83371.4466.13Price / CashN/A157.7635.4557.96Price / Book7.684.838.265.54Net Income-$14.67M$31.62M$3.25B$259.28M7 Day Performance-7.91%-5.28%-3.73%-4.67%1 Month Performance-0.71%4.38%4.28%4.38%1 Year Performance33.65%-2.49%25.85%17.90% Journey Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DERMJourney Medical2.1895 of 5 stars$6.99-4.9%$9.50+35.9%+26.4%$171.22M$56.13M-17.9290News CoverageAnalyst RevisionFBIOFortress Biotech2.4982 of 5 stars$1.98+0.5%$21.00+960.6%-13.4%$58.25M$57.67M-0.89170PHARPharming Group3.005 of 5 stars$10.00-2.5%$30.00+200.0%+43.1%$702.96M$297.20M-50.00280News CoveragePositive NewsEarnings ReportTLRYTilray Brands3.0467 of 5 stars$0.70+1.6%$1.92+173.9%-71.4%$692.97M$788.94M-0.672,650Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst RevisionGap DownDNTHDianthus Therapeutics1.2535 of 5 stars$22.28+3.6%$53.00+137.9%-26.5%$691.44M$6.24M-7.7480Upcoming EarningsMRVIMaravai LifeSciences3.7389 of 5 stars$2.65-1.5%$6.64+150.5%-76.9%$685.04M$241.86M-2.32610Gap DownMGTXMeiraGTx4.4347 of 5 stars$8.23-1.7%$24.00+191.6%+56.8%$672.66M$33.28M-3.55300News CoveragePHATPhathom Pharmaceuticals2.6591 of 5 stars$8.80-8.6%$17.50+98.9%-26.9%$672.31M$81.86M-1.68110Upcoming EarningsAUTLAutolus Therapeutics2.3416 of 5 stars$2.51-0.4%$9.32+271.3%-47.9%$670.68M$10.12M-2.85330Gap DownXNCRXencor3.4785 of 5 stars$9.03-2.3%$28.00+210.1%-59.9%$657.62M$110.49M-2.95280News CoveragePositive NewsUpcoming EarningsShort Interest ↑VALNValneva2.7159 of 5 stars$7.61-0.9%$15.50+103.7%+2.4%$653.52M$183.52M-6.39700High Trading Volume Related Companies and Tools Related Companies Fortress Biotech Competitors Pharming Group Competitors Tilray Brands Competitors Dianthus Therapeutics Competitors Maravai LifeSciences Competitors MeiraGTx Competitors Phathom Pharmaceuticals Competitors Autolus Therapeutics Competitors Xencor Competitors Valneva Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DERM) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredMicrosoft's Next Big Bet?Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-fre...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
